80 results
Page 3 of 4
6-K
EX-99.1
xqx721qydp7f96x 6ec
28 May 20
Report of Foreign Private Issuer
9:25am
6-K
EX-99.1
e7nf2s
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
sczyihwrhmk s1iyiuda
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
rydwlbmpmbrhk3f4hs
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-1.1
h4kjamu86
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
lgkyojyjf
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
7djum4 cegno1k
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
e8iq1sfd
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
4agbjo sp4x5r2v
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
kbornf0xk4
20 Nov 19
Prospectus supplement for primary offering
4:46pm
6-K
EX-99.2
ujjvw6yxlix5d2
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.2
fwp7 4ciwf0o
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
424B3
6wjbm
10 Jul 19
Prospectus supplement
8:18am
F-3
cy8ng3cjm7qdqsmt5vqz
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
zcocrmi4
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.2
fdhzlf0r pe
20 May 19
Condensed Consolidated Financial Statements
4:15pm